UPCommons. Portal del coneixement obert de la UPC
Publication
Artículo científico (JournalArticle)
Rethinking trust in synthetic health data: lessons from 7 European research initiatives
Synthetic data generation (SDG) structured health data is increasingly promoted as a solution to longstanding barriers in health data access. It is offering the promise of privacy-preserving data reuse for research, innovation, and policy. Despite rapid technical advances, the adoption of synthetic health data in real-world settings remains limited. Shaped by challenges around data quality, representativeness, infrastructure readiness, trust, and legal uncertainty, this viewpoint draws on experiences from 7 European research initiatives within the HealthData4EU cluster to reflect on how SDG is being operationalized in practice. It synthesizes cross-project insights to highlight recurring methodological and governance tensions and to examine their implications for trust and responsible use. The analysis argues that trustworthy SDG cannot be achieved through technical optimization alone but requires alignment between evaluation practices, upstream data stewardship, regulatory clarity, and sustained stakeholder engagement. Addressing these conditions is essential for moving synthetic data from experimental pilots toward a credible and sustainable component of European health research ecosystems., This paper was funded by the Innovative Health Initiative through the SYNTHIA project. The study draws on insights from 7 research projects that form part of the HealthData4EU cluster. Projects within the cluster and their funding sources are as follows. SYNTHEMA, PHASE IV AI, SECURED, FLUTE, and AISym4MED are funded by the Horizon Europe program. PHEMS is funded by Horizon Europe and UK Research and Innovation. SYNTHIA is funded through the Innovative Health Initiative., Peer Reviewed, Article signat per 18 autors/es: Jens Declerck 1,2, MSc; Dipak Kalra 1, Prof Dr; Antti Airola 3; Ahmed Youssef Ali Amer 4; Christos Chatzichristos 5; Maria del Mar Mañu Pereira 6; Bruno M. de Brito Robalo 7; Francesco Ghini 8; Alberto Gutierrez-Torre 9; Sem Hoogteijling 10; Susanne Hultsch 11; Jan Ramon 12; Sara Reidel 13,14; Francesco Regazzoni 15,16; Luís Silva 17; Inês Silveira 17; Tsekeridou Sofia 18, PhD; Christophe Maes 1,2 / 1- The European Institute for Innovation through Health Data, Oosterzele, Belgium; 2- Unit of Medical Informatics and Statistics, Department of Public Health and Primary Care, The University of Ghent, Ghent, Belgium; 3- Department of Computing, University of Turku, Turku, Finland; 4- Innovative Medicine, Johnson & Johnson, Beerse, Belgium; 5- Department of Electrical Engineering, KU Leuven, Leuven, Belgium; 6- University Hospital Vall d'Hebron, Barcelona, Spain; 7- Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; 8- Laboratory of Translational Research, Reggio Emilia, Italy; 9- Barcelona Supercomputing Center, Barcelona, Catalonia, Spain; 10- Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht, The Netherlands; 11- VEIL.AI, Helsinki, Finland; 12- Institut national de recherche en sciences et technologies du numérique, Lille, France; 13- Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain; 14- BarcelonaTech (UPC), Universitat Politècnica de Catalunya, Barcelona, Spain; 15- University of Amsterdam, Amsterdam, The Netherlands; 16- Università della Svizzera italiana, Lugano, Ticino, Switzerland; 17- Laboratory for Instrumentation, Biomedical Engineering and Radiation Physics, NOVA School of Science and Technology, Caparica, Portugal; 18- Netcompany BELUX, Athens, Greece